Fresenius | FRE - Fremdkapital





Fremdkapital Veränderung Datum
Akzo Nobel EUR 5.5B 743M 2026-06
Alcon AG USD 4.65B 491M 2026-06
AstraZeneca USD 26.01B 46M 2026-06
BASF EUR 18.83B 1.08B 2026-06
Bayer EUR 31.16B 480M 2026-06
Beiersdorf EUR 117M 15M 2025-12
DaVita Healthcare Partners USD 10.66B 150.24M 2026-06
Demant DKK 13.13B 5.86B 2026-06
E.ON EUR 38.55B 2.02B 2026-06
Essilor EUR 9.66B 190M 2026-06
Fresenius EUR 9.55B 1.24B 2026-06
Fresenius Medical Care EUR 5.82B 83.04M 2026-06
Getinge SEK 9.09B 167M 2026-06
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 13.95B 65M 2026-06
GN Store Nord DKK 8.11B 4M 2026-06
GRIFOLS EUR 7.17B 1.91B 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 11.21B 406M 2026-06
Novartis USD 37.49B 42M 2026-06
Philips EUR 6.32B 575M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
RWE EUR 7.57B 8.86B 2026-06
Sanofi EUR 14.65B 806M 2026-06
Smith & Nephew USD 3.21B 85M 2026-06